We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

CellaVision Introduces Analyzers into the Japanese Market

By LabMedica International staff writers
Posted on 03 Oct 2008
CellaVision (Lund, Sweden) develops and sells digital morphology (DM) products for the routine analysis of blood and other body fluids. In March 2008, the company established a subsidiary in Japan--CellaVision Japan K.K. (Yokohama, Japan). Official approval has been given for the subsidiary to market the company's analyzers in Japan.

The Japanese authority, Pharmaceuticals and Medical Device Agency (PMDA) issued the product registration. The Japanese subsidiary was opened during a ceremony at the Swedish Embassy in Tokyo on the September 11, 2008. On October 9-11, 2008, CellaVision's products will be presented at Japan's largest convention for clinical laboratory products, the Japanese Society for Clinical Laboratory Automation (JSCLA). Around 7,000 participants in the field of clinical chemistry are expected to attend.

"The establishment of our Japanese subsidiary is advancing according to plan and it is satisfying to now be active on the Japanese market. We hope to be completely operative before the end of the year,” said CellaVision's CEO Yvonne Martensson. "It is important for us to meet potential clients on site in order to demonstrate how also Japanese laboratories can benefit from CellaVision's digital morphology technology. We see considerable potential in the Japanese market.”

There are approximately 9,000 hospitals and 900 commercial laboratories in Japan, which has large potential for medical technology products in general. CellaVision will focus primarily on the 1,000 larger hospital and commercial laboratories that will benefit the most from automating their processes.

CellaVision develops software and hardware for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white and red blood cell morphology, software for education, and for quality assurance of differentials.

Related Links:
CellaVision
Japanese Society for Clinical Laboratory Automation



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Tabletop Centrifuge
Mikro 185
New
Liquid Based Cytology Production Machine
LBP-4032

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests